Anteris Technologies Global Corp. (AVR) stock
AVRNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$5.32−0.38 (-6.67%)
Close on Nov 17, 2026Market cap $518.48MP/E –Yield –
Anteris Technologies Global r&d expenses
Research and development expenses are spending on new products and technology.
Anteris Technologies Global's R&D Expenses for the twelve months ending Sep 30, 2026 was $81.67M, up 29.8% year over year. For fiscal 2025 it was $69.12M, up 34.3% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $69.12M | +34.3% |
| FY2024 | Dec 31, 2024 | $51.45M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $21.33M | +26.9% |
| Q2 FY2026 | Jun 30, 2026 | $23.37M | +43.0% |
| Q1 FY2026 | Mar 31, 2026 | $17.46M | +6.1% |
| Q4 FY2025 | Dec 31, 2025 | $19.51M | +46.5% |
| Q3 FY2025 | Sep 30, 2025 | $16.81M | +20.5% |
| Q2 FY2025 | Jun 30, 2025 | $16.34M | +29.3% |
| Q1 FY2025 | Mar 31, 2025 | $16.46M | +42.4% |
| Q4 FY2024 | Dec 31, 2024 | $13.32M | – |
| Q3 FY2024 | Sep 30, 2024 | $13.95M | – |
| Q2 FY2024 | Jun 30, 2024 | $12.63M | – |
| Q1 FY2024 | Mar 31, 2024 | $11.56M | – |
See a number that looks wrong?